[Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
Mori
Keiko
K
Hattori
Naoki
N
Sobue
Gen
G
D019317:Evidence-Based Medicine; D020275:Guillain-Barre Syndrome / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010951:Plasma Exchange; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000628:therapy; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012015:Reference Standards
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D011239:Prednisolone